• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用LiESP/QA-21疫苗(CaniLeish)进行初次疫苗接种会产生细胞介导的免疫反应,这种反应在一年后仍然存在。

Primary vaccination with the LiESP/QA-21 vaccine (CaniLeish) produces a cell-mediated immune response which is still present 1 year later.

作者信息

Moreno Javier, Vouldoukis Ioannis, Schreiber Paul, Martin Virginie, McGahie David, Gueguen Sylvie, Cuisinier Anne-Marie

机构信息

WHO Collaborating Centre for Leishmaniasis, Centro Nacional de Microbiologia, Instituto de Carlos III, Madrid, Spain.

INSERM UMR S 945, Immunité et Infection, Faculté de Médecine Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France.

出版信息

Vet Immunol Immunopathol. 2014 Apr 15;158(3-4):199-207. doi: 10.1016/j.vetimm.2014.01.011. Epub 2014 Jan 28.

DOI:10.1016/j.vetimm.2014.01.011
PMID:24560650
Abstract

Canine leishmaniasis, an important zoonotic disease of dogs, is the result of an ineffective and inappropriate immune response to infection with Leishmania infantum. It is widely accepted that the appropriate immune response is characterised by a T-helper (Th)1-dominated profile in an overall mixed Th1/Th2 response. The absence of a strong Th1 response is associated with progression to the clinical disease. Thus, there is a need for an effective vaccine that could modulate the immune response to a more appropriate profile against the parasite. In this study we measured the impact of the LiESP/QA-21 canine vaccine, recently launched commercially in Europe, on selected humoral and cellular immune markers for one year after a primary vaccination course. The humoral response to vaccination was characterised by a predominantly IgG2 profile. Vaccinated dogs developed long-lasting cell-mediated immune responses against L. infantum, specifically with a stronger ability of macrophages to reduce intracellular parasite burdens in co-culture with autologous lymphocytes compared to control dogs (p=0.0002), which was correlated with induction of inducible nitric oxide synthase (iNOS) and production of nitric oxide (NO) derivatives. These results confirm that vaccination with LiESP/QA-21 is capable of inducing an appropriate Th1-dominated immune profile which persists for a full year.

摘要

犬利什曼病是一种重要的犬类人畜共患病,是对婴儿利什曼原虫感染的免疫反应无效且不适当的结果。人们普遍认为,适当的免疫反应的特征是在整体混合的Th1/Th2反应中以辅助性T细胞(Th)1为主导。缺乏强烈的Th1反应与临床疾病的进展有关。因此,需要一种有效的疫苗,能够将免疫反应调节为针对该寄生虫的更适当的状态。在本研究中,我们测量了最近在欧洲商业推出的LiESP/QA-21犬用疫苗在初次接种疫苗疗程后一年内对选定的体液和细胞免疫标志物的影响。对疫苗接种的体液反应主要以IgG2状态为特征。接种疫苗的犬对婴儿利什曼原虫产生了持久的细胞介导免疫反应,特别是与对照犬相比,巨噬细胞在与自体淋巴细胞共培养时具有更强的降低细胞内寄生虫负荷的能力(p=0.0002),这与诱导型一氧化氮合酶(iNOS)的诱导和一氧化氮(NO)衍生物的产生相关。这些结果证实,用LiESP/QA-21疫苗接种能够诱导持续一整年的适当的以Th1为主导的免疫状态。

相似文献

1
Primary vaccination with the LiESP/QA-21 vaccine (CaniLeish) produces a cell-mediated immune response which is still present 1 year later.使用LiESP/QA-21疫苗(CaniLeish)进行初次疫苗接种会产生细胞介导的免疫反应,这种反应在一年后仍然存在。
Vet Immunol Immunopathol. 2014 Apr 15;158(3-4):199-207. doi: 10.1016/j.vetimm.2014.01.011. Epub 2014 Jan 28.
2
Canine Leishmania vaccines: still a long way to go.犬利什曼原虫疫苗:仍有很长的路要走。
Vet Parasitol. 2015 Feb 28;208(1-2):94-100. doi: 10.1016/j.vetpar.2015.01.003. Epub 2015 Jan 15.
3
The protective immune response produced in dogs after primary vaccination with the LiESP/QA-21 vaccine (CaniLeish®) remains effective against an experimental challenge one year later.初次接种 LiESP/QA-21 疫苗(CaniLeish®)后,犬体内产生的保护性免疫应答在一年后仍能有效抵抗实验性挑战。
Vet Res. 2014 Jun 25;45(1):69. doi: 10.1186/1297-9716-45-69.
4
Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.在法国流行地区使用LiESAp-MDP疫苗对犬内脏利什曼病进行长期保护:双盲随机疗效现场试验。
Vaccine. 2007 May 22;25(21):4223-34. doi: 10.1016/j.vaccine.2007.02.083. Epub 2007 Mar 15.
5
Use of a LiESP/QA-21 vaccine (CaniLeish) stimulates an appropriate Th1-dominated cell-mediated immune response in dogs.LiESP/QA-21 疫苗(CaniLeish)的使用可刺激犬产生适当的 Th1 型优势细胞介导的免疫应答。
PLoS Negl Trop Dis. 2012;6(6):e1683. doi: 10.1371/journal.pntd.0001683. Epub 2012 Jun 19.
6
Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.亚马逊利什曼原虫分泌型前鞭毛体表面抗原(PSA)的重组形式可诱导犬产生保护性免疫反应。
PLoS Negl Trop Dis. 2016 May 25;10(5):e0004614. doi: 10.1371/journal.pntd.0004614. eCollection 2016 May.
7
Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.用编码KMPII、TRYP、LACK和GP63的质粒DNA进行疫苗接种不能保护犬只免受婴儿利什曼原虫实验性攻击。
Vaccine. 2007 Nov 14;25(46):7962-71. doi: 10.1016/j.vaccine.2007.08.023. Epub 2007 Aug 30.
8
Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.使用减毒活利什曼原虫中心体缺失寄生虫进行疫苗接种可诱导狗对利什曼原虫感染产生保护作用。
Vaccine. 2015 Jan 3;33(2):280-8. doi: 10.1016/j.vaccine.2014.11.039. Epub 2014 Dec 1.
9
Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.用婴儿利什曼原虫前鞭毛体纯化的排泄分泌抗原来免疫的犬对实验性内脏利什曼病感染的保护作用。
Vaccine. 2005 Apr 22;23(22):2825-40. doi: 10.1016/j.vaccine.2004.11.061.
10
Vaccination with LiESP/QA-21 (CaniLeish®) reduces the intensity of infection in Phlebotomus perniciosus fed on Leishmania infantum infected dogs--a preliminary xenodiagnosis study.LiESP/QA-21(CaniLeish®)疫苗接种可降低感染利什曼原虫的感染犬的白蛉属按蚊叮咬后感染强度——初步的异种诊断研究。
Vet Parasitol. 2013 Nov 8;197(3-4):691-5. doi: 10.1016/j.vetpar.2013.05.008. Epub 2013 May 17.

引用本文的文献

1
An update on recombinant vaccines against leishmaniasis.抗利什曼病重组疫苗的最新进展。
Indian J Med Res. 2024;160(3&4):323-337. doi: 10.25259/IJMR_1040_2024.
2
Treatment and Healing of Leishmaniasis in a Wolf in Semi-Captivity Regime from an Educational Center of Zamora Province (Spain).西班牙萨莫拉省一个教育中心半圈养状态下一只狼的利什曼病治疗与康复情况
Animals (Basel). 2024 May 11;14(10):1436. doi: 10.3390/ani14101436.
3
Therapeutic Potential of Photosynthetic Microorganisms for Visceral Leishmaniasis: An Immunological Analysis.
光合微生物治疗内脏利什曼病的潜力:免疫学分析。
Front Immunol. 2022 Jun 30;13:891495. doi: 10.3389/fimmu.2022.891495. eCollection 2022.
4
Stage-Specific Class I Nucleases of Play Important Roles in Parasite Infection and Survival.阶段特异性 I 类核酸内切酶在寄生虫感染和存活中发挥重要作用。
Front Cell Infect Microbiol. 2021 Oct 15;11:769933. doi: 10.3389/fcimb.2021.769933. eCollection 2021.
5
Diagnosis and clinical management of canine leishmaniosis by general veterinary practitioners: a questionnaire-based survey in Portugal.葡萄牙兽医全科医生对犬利什曼病的诊断和临床管理:一项基于问卷调查的研究。
Parasit Vectors. 2021 Jun 7;14(1):306. doi: 10.1186/s13071-021-04799-y.
6
Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines.兽医学中的新型疫苗技术:人类医学疫苗的先驱
Front Vet Sci. 2021 Apr 15;8:654289. doi: 10.3389/fvets.2021.654289. eCollection 2021.
7
Immunoprophylactic Potential of a New Recombinant Antigen for Canine Visceral Leishmaniasis: An Finding.一种新的犬内脏利什曼病重组抗原的免疫预防潜力:一项发现。
Front Immunol. 2021 Jan 8;11:605044. doi: 10.3389/fimmu.2020.605044. eCollection 2020.
8
Latest trends in L. infantum infection in dogs in Spain, Part II: current clinical management and control according to a national survey of veterinary practitioners.西班牙犬利什曼原虫感染的最新趋势,第二部分:根据兽医从业者的全国调查,当前的临床管理和控制。
Parasit Vectors. 2020 Apr 21;13(1):205. doi: 10.1186/s13071-020-04080-8.
9
The Use of Specific Serological Biomarkers to Detect CaniLeish Vaccination in Dogs.使用特定血清生物标志物检测犬利什曼原虫疫苗接种情况。
Front Vet Sci. 2019 Oct 24;6:373. doi: 10.3389/fvets.2019.00373. eCollection 2019.
10
Assessment of Vaccine-Induced Immunity Against Canine Visceral Leishmaniasis.犬内脏利什曼病疫苗诱导免疫的评估
Front Vet Sci. 2019 Jun 4;6:168. doi: 10.3389/fvets.2019.00168. eCollection 2019.